𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long term experience with oral gold in psoriatic arthritis

✍ Scribed by P. Barbieri; M. L. Ciompi; C. Bini; G. Pasero

Publisher
Springer
Year
1986
Tongue
English
Weight
152 KB
Volume
5
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab for long-term treatment of ps
Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
✍ Dafna D. Gladman; Philip J. Mease; Christopher T. Ritchlin; Ernest H. S. Choy; J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of treatment with adalimumab, a fully human anti–tumor necrosis factor (anti‐TNF) monoclonal antibody, over 48 weeks in patients with moderate to severe psoriatic arthritis (PsA). ## Methods Patients who completed the Adalimumab Effect

Long-term experience with bromocriptine
Long-term experience with bromocriptine in advanced parkinsonism
✍ E. Schneider; P. -A. Fischer πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 521 KB

The long-term effects of bromocriptine as an adjuvant were investigated in 32 patients (20 male, 12 female), aged 43-76 years (mean 65.4), suffering from parkinsonism for 3-20 years (mean 9.3). Patients were pretreated with levodopa/decarboxylase inhibitor for 24-116 months (mean 74.9). Bromocriptin